AstraZeneca PLC vs Royal Bank of Canada
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
AstraZeneca PLC
$266.0B
μμ #52
Royal Bank of Canada
$284.8B
μμ #47
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Royal Bank of Canadaμ΄(κ°) 2026λ κΉμ§ AstraZeneca PLCμ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | AstraZeneca PLC | Royal Bank of Canada | μ λ |
|---|---|---|---|
| 2026 | $266.0B | $284.8B | Royal Bank of Canada |
| 2025 | $282.2B | $234.1B | AstraZeneca PLC |
| 2024 | $196.9B | $167.7B | AstraZeneca PLC |
| 2023 | $198.1B | $124.8B | AstraZeneca PLC |
| 2022 | $195.3B | $113.7B | AstraZeneca PLC |
| 2021 | $163.9B | $115.4B | AstraZeneca PLC |
| 2020 | $136.9B | $86.7B | AstraZeneca PLC |
| 2019 | $132.8B | $81.4B | AstraZeneca PLC |
| 2018 | $97.9B | $71.2B | AstraZeneca PLC |
| 2017 | $85.9B | $75.4B | AstraZeneca PLC |
| 2016 | $64.5B | $64.3B | AstraZeneca PLC |
| 2015 | $76.6B | $50.3B | AstraZeneca PLC |
| 2014 | $76.2B | $52.3B | AstraZeneca PLC |
| 2013 | $61.7B | $44.9B | AstraZeneca PLC |
| 2012 | $46.3B | $36.2B | AstraZeneca PLC |
| 2011 | $42.7B | $30.1B | AstraZeneca PLC |
| 2010 | $40.3B | $29.2B | AstraZeneca PLC |
| 2009 | $38.9B | $30.3B | AstraZeneca PLC |
| 2008 | $32.3B | $18.5B | AstraZeneca PLC |
| 2007 | $32.3B | $24.9B | AstraZeneca PLC |
| 2006 | $39.1B | $26.4B | AstraZeneca PLC |
| 2005 | $34.5B | $20.9B | AstraZeneca PLC |
| 2004 | $25.2B | $14.4B | AstraZeneca PLC |
| 2003 | $32.9B | $13.4B | AstraZeneca PLC |
| 2002 | $23.4B | $12.3B | AstraZeneca PLC |
| 2001 | $30.5B | $10.7B | AstraZeneca PLC |
| 2000 | $33.1B | $10.2B | AstraZeneca PLC |
| 1999 | $25.7B | $6.2B | AstraZeneca PLC |
| 1998 | $27.2B | $7.2B | AstraZeneca PLC |
| 1997 | $21.4B | $7.0B | AstraZeneca PLC |
| 1996 | $16.3B | $4.3B | AstraZeneca PLC |
| 1995 | $11.1B | $2.7B | AstraZeneca PLC |